MEDAVAIL HOLDINGS INC MYOS
COM · Common Stock · CUSIP 58406B103
1
institutional holders
-27 vs Q2 2023
300.6k
shares reported held*
$1.8mreported value*
0 new
0 added
1 reduced
27 sold out
net sold ≈ $403.1m (-67.2m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $6.00.
Trends to Q3 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 34 |
| Q4 2022 | 33 |
| Q1 2023 | 28 |
| Q2 2023 | 28 |
| Q3 2023 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 9 | 11 |
| Q1 2023 | 5 | 10 |
| Q2 2023 | 4 | 8 |
| Q3 2023 | 0 | 28 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q4 2022 | $6.0k | $0 | 0.00 |
| Q1 2023 | $892.3k | $0 | 0.00 |
| Q2 2023 | $38.2m | $0 | 0.00 |
| Q3 2023 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| Redmile Group, LLC | Sold out | -34.6m |
| ABG-WTT Global Life Science Capital Partners GP Ltd | Reduced | -14.7m |
| Alyeska Investment Group, L.P. | Sold out | -6.0m |
| Ally Bridge Group (NY) LLC | Sold out | -5.9m |
| CIGNA INVESTMENTS INC /NEW | Sold out | -2.4m |
| VANGUARD GROUP INC | Sold out | -1.1m |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Sold out | -1.0m |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Sold out | -836.6k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -183.9k |
| BlackRock Inc. | Sold out | -101.8k |
Holders, Q3 2023
| Manager | Shares | Change |
|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd 8.65% of their portfolio | 300.6k $1.8m | Reduced -14.7m |